Dow Jones

39 872,99

0,17%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
AMEX
Callisto Pharmaceuticals, (KAL)
Callisto Pharmaceuticals, (KAL) Actualités

KAL

Callisto (KAL)

Callisto Pharmaceuticals,

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:KAL

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
25/05/2015	04h00	Dow Jones News	Strike Worsens Nigeria Fuel Crisis	NASDAQ:KAL	Kenya Airways Ltd.
04/10/2012	18h04	Dow Jones News	Cameroon To Buy Two Boeing Aircraft -Official	AMEX:KAL	Callisto Pharmaceuticals,
05/09/2011	13h03	Dow Jones News	Kenya Airways To Buy 10 E190 Jets From Brazil's Embraer -Report	NASDAQ:KAL	Kenya Airways Ltd.
14/04/2011	19h52	Dow Jones News	Kenya Airways Reaches Deal With Boeing Over 787 Delivery	NASDAQ:KAL	Kenya Airways Ltd.
08/06/2010	15h55	Dow Jones News	Air France-KLM Isn't Seeking M&A Deals Right Now - KLM CEO	NASDAQ:KAL	Kenya Airways Ltd.
16/04/2010	14h20	Dow Jones News	UPDATE: SkyTeam In Talks With Candidates For Expansion	NASDAQ:KAL	Kenya Airways Ltd.
08/07/2008	22h46	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Current report filing (8-K)	AMEX:KAL	Callisto Pharmaceuticals,
15/05/2008	22h05	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:KAL	Callisto Pharmaceuticals,
02/05/2008	20h04	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	AMEX:KAL	Callisto Pharmaceuticals,
24/04/2008	12h01	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)	AMEX:KAL	Callisto Pharmaceuticals,
16/04/2008	22h47	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Securities Registration Statement (simplified form) (S-3)	AMEX:KAL	Callisto Pharmaceuticals,
11/04/2008	22h07	Business Wire	Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -	AMEX:KAL	Callisto Pharmaceuticals,
28/03/2008	11h01	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Annual Report (10-K)	AMEX:KAL	Callisto Pharmaceuticals,
14/02/2008	19h57	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Statement of Ownership (SC 13G)	AMEX:KAL	Callisto Pharmaceuticals,
30/01/2008	19h55	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)	AMEX:KAL	Callisto Pharmaceuticals,
25/10/2007	16h33	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	AMEX:KAL	Callisto Pharmaceuticals,
01/10/2007	23h01	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc (Other) (8-K)	AMEX:KAL	Callisto Pharmaceuticals,
28/09/2007	19h53	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc (Other) (424B3)	AMEX:KAL	Callisto Pharmaceuticals,
28/09/2007	16h54	Edgar (US Regulatory)	Callisto Pharmaceuticals Inc (Other) (4)	AMEX:KAL	Callisto Pharmaceuticals,
20/09/2007	13h07	PR Newswire (US)	Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer	NASDAQ:KAL
29/08/2007	15h00	PR Newswire (US)	American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards	NASDAQ:KAL
11/08/2007	02h05	PR Newswire (US)	Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines	NASDAQ:KAL
09/08/2007	14h00	PR Newswire (US)	Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients	NASDAQ:KAL
08/08/2007	14h00	PR Newswire (US)	Callisto Reports on Second-Quarter 2007 Milestones	NASDAQ:KAL
07/08/2007	14h00	PR Newswire (US)	Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing	NASDAQ:KAL
25/06/2007	14h00	PR Newswire (US)	Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients	NASDAQ:KAL
22/06/2007	23h05	PR Newswire (US)	Callisto Pharmaceuticals, Inc. Receives Notice From AMEX	AMEX:KAL	Callisto Pharmaceuticals,
08/06/2007	16h30	PR Newswire (US)	Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio	NASDAQ:KAL
24/05/2007	16h00	PR Newswire (US)	Callisto Pharmaceuticals Opens Fourth Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients	NASDAQ:KAL
15/05/2007	18h24	PR Newswire (US)	Callisto Pharmaceuticals Announces Article Citing Atiprimod in Major Scientific News Journal	NASDAQ:KAL